Navigation Links
China Biologic Receives SFDA Approval for Clinical Trial of Human Coagulation Factor VIII
Date:9/17/2008

TAIAN CITY, Shandong, China, Sept. 17 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that the Company received approval from the PRC State Food and Drug Administration (the "SFDA") to commence clinical trial of its new Human Coagulation Factor VIII product ("FVIII"), a coagulation treatment for hemophilia and mass hemorrhaging.

As one of four suppliers of Cryoprecipitate in China, China Biologic has been engaged in a contract to supply Cryoprecipitate to Green Cross China for use in the production of FVIII. With its own supply of Cryoprecipitate and its continued research and development of FVIII, the Company has obtained approval to commence clinical trial for 200 IU and 300 IU per dose of FVIII.

China Biologic has commenced preparations for the clinical study and expects to receive results by mid-2009. If the clinical study is successful, management expects to get SFDA's approval for production to launch the product at the beginning of 2010.

"We are pleased that our continued focus on research and development has led us to receive approval from the SFDA for clinical trial of FVIII," said Mr. Chao Ming Zhao, the Company's CEO. "The approval represents a significant milestone on diversifying our product portfolio. In addition, we believe our ability to produce Cryoprecipitate from clinical extra plasma - plasma that would have been discarded previously - will yield a higher gross profit margin in the production of FVIII."

About China Biologic Products, Inc.

Through its indirect majority-owned subsidiary, Shandong Taibang Biological Products Co. Ltd., China Biologic Products, Inc. (the "Company"), is principally engaged in the research, development, production and manufacturing and sale of plasma-based biopharmaceutical products to h
'/>"/>

SOURCE China Biologic Products, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...RONTO,Nov.24/PRNewswire-FirstCall/-HamiltonThorneL...providerofadvancedlasersystemsandinstrumentsforthe...ortedoperationalandfinancialresultsforthethirdquar...evenuewas$1.46millioncomparedwith$1.43millioninQ32....1percentinQ3,2008,-Netlossreducedto$148,000compar...
(Date:11/24/2009)...4/PRNewswire-FirstCall/--GenomicHealth,Inc.(Nasdaq...,sExecutiveChairman,willpresentatthe21stAnnualPipe...,December1,2009at10:00a.m.ET. ,, Toaccesstheliv...isittheInvestorRelationssectionofGenomicHealth,swe...onnecttothewebsiteatleast15minutespriortothebeginn...
(Date:11/24/2009)...al Abstracts Service (CAS), the global expert on c...ffice is now the world,s leading producer of paten...ed Japan,s patent office, the World Intellectual P... Patent and Trademark Office (USPTO) for more than...006, and exceeded Japan for the first time on a mo...
(Date:11/23/2009)... of it as origami very high-tech origami. , Rese...ed a technique for fabricating three-dimensional, ...lms by coupling photolithography and a self-foldin... films, only a few microns thick, offer mechanical...ces of the same material. , "This is a completely...
Breaking Biology Technology:Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Genomic Health to Present at Piper Jaffray Health Care Conference 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3Water droplets direct self-assembly process in thin-film materials 2
...als, Inc. (Nasdaq: ISIS ) announced today that it...(Ibis), has been awarded four new,government contr...tection,and identification of microbial threat age...ntracts are from the Department of Homeland Securi...d total up to approximately,$3.3 million and a fou...
...SE: EHP) announced today that it has completed the... for potential biodefense drugs, and are,about to ...over the coming,year. The National Institutes of ...logical and Nuclear Threats (MCART) programme lead...ion sickness following a nuclear terrorist,attack....
...:,BIOD) today announced that it will amend its Qua...d ended June 30, 2007 to correct the manner in whi...nsation expense arising from,stock options granted...any,s initial public offering. The amendment will ...olely non-cash in nature. On May 10, 2007, the Co...
Other Biology Technology:Isis Announces $4.2 Million in Government Contracts Awarded to Its Ibis Subsidiary for Biodefense Applications Development 2Isis Announces $4.2 Million in Government Contracts Awarded to Its Ibis Subsidiary for Biodefense Applications Development 3Isis Announces $4.2 Million in Government Contracts Awarded to Its Ibis Subsidiary for Biodefense Applications Development 4EpiStem Successfully Complete First Year of Mucositis Tests for NIH Biodefence Programme 2EpiStem Successfully Complete First Year of Mucositis Tests for NIH Biodefence Programme 3Biodel to Amend June 30, 2007 10-Q to Correct Non-Cash Share-Based Compensation Expense 2Biodel to Amend June 30, 2007 10-Q to Correct Non-Cash Share-Based Compensation Expense 3
(Date:11/23/2009)...ence that the "synergistic" effect of early-life e...and indoor endotoxin causes more harm to developin... Environmental health scientists at the Universit...n that children exposed to both high levels of tra... early life are six times more likely to experienc...
(Date:11/23/2009)...plied mathematicians dissected the morphology of t...istic long leaf with a saddle-like arc midsection ...mple cause of the lily,s fan-like shapeelastic rel... growthwas revealed by using an equally simple tec...a postdoctoral student at Harvard,s School of Engi...
(Date:11/23/2009)...Society says that western lowland gorillas living ...he "mother lode" of more than 125,000 gorillas dis...ned by growing humans activity in the region. , ...ts adjacent to the southwest border of Lac Tl Comm...high densities of the great apes still exist in th...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2The cause behind the characteristic shape of a long leaf revealed 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Watchful waiting is a viable option for prostate cancer patients with low risk tumors 55761 1Watchful waiting is a viable option for prostate cancer patients with low risk tumors 55761 2Watchful waiting is a viable option for prostate cancer patients with low risk tumors 55761 3Abbott to Present at Morgan Stanley Global Healthcare Unplugged Conference 55759 1Family Circle Magazine Features AmLactin 28R 29 in Article on Managing Dry Skin Associated With Keratosis Pilaris 55757 1Family Circle Magazine Features AmLactin 28R 29 in Article on Managing Dry Skin Associated With Keratosis Pilaris 55757 2
...or bioengineered crops, sequencing the genome coul.... Once the sequence is complete, the baton is pass...ions. A draft sequence of the soybean genome is no...able soon. Taking the next step in a new study, Un... researchers have demonstrated the applicability o...
...entory" of sea and land animals around a group of ... biodiversity and has more species than the Galapa...monitor how they will respond to future environmen... of Biogeography , the team from British Antarctic...ey combed the land, sea and shores of the South Or...
...(Sweden) Permission has been granted to start the...or a remedy for ALS. ALS is an incurable, paralyzi...ns in every 100,000. The disease commonly affects ...lives − without warning. Researchers from VI...ibilities for the use of VEGF in the treatment of ...
Other Biology News:Tool helps identify gene function in soybeans 2First trial in patients with a potential treatment of the incurable ALS muscle disease 2First trial in patients with a potential treatment of the incurable ALS muscle disease 3
...DA-GT12 Genetic Analyzer is a revolutionary multi...ultiple applications in one instrument platform. I...data analysis in one step, thus significantly impr... of medium to high-throughput laboratories . Bene...
...otofor purification system, 100-120 V, is used for...se isoelectric focusing (IEF). The system includes...ng chambers, chassis, harvesting apparatus, coolin...lytes (pH 3-10), 60 ml syringe, colored protein sa...
...mmEdge Pen, a hydrophobic barrier pen for immunohi...ed for use with frozen or paraffin-embedded tissue... provides a heat-stable, water-repellent barrier t...e sections, prevents mixing of reagents when diffe...
NBT/BCIP Chromogen System (SIGNET) from Covance Research Products, Inc
Biology Products: